A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Vinorelbine EP Impurity I - Request Quote

Picture of Vinorelbine EP Impurity I

Vinorelbine EP Impurity I

SZ CAT No:SZ-V020011
CAS No
NA
Mol.F.
C45H53BrN4O8
Mol.Wt.
857.9
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Vinorelbine EP Impurity I is chemically 17-Bromo-4′-deoxy-3′,4′-didehydro-8′-norvincaleukoblastine (as per EP). Vinorelbine EP Impurity I is supplied with detailed characterization data compliant with regulatory guideline. Vinorelbine EP Impurity I can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pharmaceutical Reference Standards.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Vinorelbine EP Impurity I

Purchase Vinorelbine EP Impurity I

Vinorelbine EP Impurity I suppliers

Vinorelbine EP Impurity I manufacturers

Vinorelbine EP Impurity I price

Order Vinorelbine EP Impurity I

Enquire Vinorelbine EP Impurity I

Vinorelbine EP Impurity I cost

Vinorelbine EP Impurity I Supplier

Vinorelbine EP Impurity I Distributor

Vinorelbine EP Impurity I for Method Validation

Pharmaceutical Reference Standards Reference Standard

Vinorelbine EP Impurity I for ANDA Filing

Vinorelbine EP Impurity I for Forced Degradation Studies

Vinorelbine EP Impurity I Identification Standards

Vinorelbine EP Impurity I for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,